MedPath

Out-of Pocket Payments With Lymphedema in France

Completed
Conditions
Primary Lymphedema Secondary Lymphedema
Registration Number
NCT02988505
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Lymphedema is a frequent and chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. Our aim was to analyze the distributive effects of OOPP for lymphedema patients in France.

A prospective, multicenter study will be conducted in France in 2014 on patients with lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. We will combine concentration curves and concentration indices to assess the distributive effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The mean monthly out-of-pocket payment as assessed by an online self-questionnaire6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Departement information Medicale CHU Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath